10x Genomics, Inc.
NASDAQ:TXG · NASDAQ Global Select
+$2.49 today
Vol 3.61M · Avg 3.06M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+222.10%
Period High
$34.76
Period Low
$10.79
Latest
$34.76
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Guardian Pharmacy Services, Inc.
NYSE:GRDN
$2.73B
Progyny, Inc.
NASDAQ:PGNY
$2.06B
Nuvation Bio Inc.
NYSE:NUVB
$1.87B
Omnicell, Inc.
NASDAQ:OMCL
$1.76B
Sionna Therapeutics, Inc.
NASDAQ:SION
$1.67B
Teladoc Health, Inc.
NYSE:TDOC
$1.39B
Schrödinger, Inc.
NASDAQ:SDGR
$1.15B
Omada Health
NASDAQ:OMDA
$1.01B
Certara, Inc.
NASDAQ:CERT
$894.50M
Janux Therapeutics, Inc.
NASDAQ:JANX
$857.44M
What is the latest TXG filing?
The latest filing shown is 4 dated Jun 8, 2026.
How many recent filings does TXG have?
Intrinsic Alpha currently shows 20 recent filings for TXG.
Explore More
Continue the stock analysis
Jump to another research area for this company.